Breaking News, Financial News

Financial Report: PAREXEL

Revenues up 11% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PAREXEL 4Q Revenues: $585.1 million (+11%) 4Q Earnings: $40.1 million (+34%) FY Revenues: $2.3 billion (+14%) FY Earnings: $129.1 million (+34%) Comments: Consolidated service revenue increased 10% in the quarter to $510.6 million, with $385.6 million in Clinical Research Services (CRS), $55.2 million in PAREXEL Consulting (PC), and $69.8 million in PAREXEL Informatics (PI). For the year consolidated service revenue was up 12% to $1.9 billion, with $1.5 billion in CRS, $216.2 million in PC,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters